| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.926 | 0.002 | 0.926 | 5 Hydroxytryptamine uptake inhibitor | 0.81 0.003 DBMET03702 0.842 0.003 DBMET03703 | ||
| 0.894 | 0.002 | 0.894 | Adrenaline uptake inhibitor | 0.762 0.002 DBMET03702 0.813 0.002 DBMET03703 | ||
| 0.71 | 0.003 | 0.71 | Sigma receptor agonist | 0.686 0.003 DBMET03702 0.685 0.003 DBMET03703 | ||
| 0.539 | 0.039 | 0.539 | Analgesic | 0.242 0.189 DBMET03702 0.484 0.054 DBMET03703 | ||
| 0.415 | 0.003 | 0.415 | Dopamine transporter inhibitor | 0.281 0.004 DBMET03702 0.312 0.003 DBMET03703 | ||
| 0.365 | 0.004 | 0.365 | Dopamine uptake inhibitor | 0.181 0.007 DBMET03702 0.267 0.005 DBMET03703 | ||
| 0.342 | 0.005 | 0.504 | NMDA receptor antagonist | 0.197 0.015 DBMET03702 0.504 0.004 DBMET03703 | DBMET03703 | |
| 0.335 | 0.005 | 0.349 | Opioid kappa receptor antagonist | 0.314 0.005 DBMET03702 0.349 0.005 DBMET03703 | DBMET03703 | |
| 0.315 | 0.004 | 0.43 | NMDA 2A receptor antagonist | 0.157 0.006 DBMET03702 0.43 0.003 DBMET03703 | DBMET03703 | |
| 0.309 | 0.029 | 0.382 | Tyrosine 3 hydroxylase inhibitor | 0.308 0.029 DBMET03702 0.382 0.01 DBMET03703 | DBMET03703 | |
| 0.283 | 0.011 | 0.283 | Glutamate receptor antagonist | 0.152 0.05 DBMET03702 0.257 0.014 DBMET03703 | ||
| 0.309 | 0.04 | 0.367 | 5 Hydroxytryptamine uptake stimulant | 0.367 0.021 DBMET03702 0.3 0.045 DBMET03703 | DBMET03702 | |
| 0.271 | 0.006 | 0.306 | Opioid antagonist | 0.224 0.01 DBMET03702 0.306 0.005 DBMET03703 | DBMET03703 | |
| 0.267 | 0.005 | 0.393 | NMDA 2 receptor antagonist | 0.105 0.029 DBMET03702 0.393 0.004 DBMET03703 | DBMET03703 | |
| 0.305 | 0.049 | 0.381 | Superoxide dismutase inhibitor | 0.248 0.075 DBMET03702 0.381 0.03 DBMET03703 | DBMET03703 | |
| 0.318 | 0.064 | 0.348 | Spasmolytic | 0.216 0.108 DBMET03702 0.348 0.053 DBMET03703 | DBMET03703 | |
| 0.267 | 0.028 | 0.267 | Lipocortins synthesis antagonist | 0.205 0.053 DBMET03702 0.252 0.033 DBMET03703 | ||
| 0.226 | 0.004 | 0.346 | NMDA receptor subunit 3B antagonist | 0.065 0.017 DBMET03702 0.346 0.003 DBMET03703 | DBMET03703 | |
| 0.229 | 0.008 | 0.253 | Analgesic, opioid | 0.085 0.042 DBMET03702 0.253 0.007 DBMET03703 | DBMET03703 | |
| 0.224 | 0.004 | 0.36 | NMDA receptor subunit 3A antagonist | 0.064 0.016 DBMET03702 0.36 0.003 DBMET03703 | DBMET03703 | |
| 0.22 | 0.017 | 0.221 | GABA C receptor agonist | 0.221 0.017 DBMET03702 0.21 0.019 DBMET03703 | DBMET03702 | |
| 0.197 | 0.009 | 0.232 | Opioid mu receptor antagonist | 0.169 0.014 DBMET03702 0.232 0.006 DBMET03703 | DBMET03703 | |
| 0.266 | 0.082 | 0.42 | 5 Hydroxytryptamine release stimulant | 0.42 0.042 DBMET03702 0.269 0.081 DBMET03703 | DBMET03702 | |
| 0.253 | 0.071 | 0.253 | 5 Hydroxytryptamine 1E antagonist | 0.176 0.159 DBMET03702 0.244 0.081 DBMET03703 | ||
| 0.259 | 0.087 | 0.274 | Ca(v)3.3 blocker | 0.274 0.068 DBMET03702 | DBMET03702 | |
| 0.183 | 0.014 | 0.214 | Opioid delta receptor antagonist | 0.133 0.023 DBMET03702 0.214 0.009 DBMET03703 | DBMET03703 | |
| 0.227 | 0.061 | 0.247 | Anesthetic general | 0.247 0.052 DBMET03703 | DBMET03703 | |
| 0.159 | 0.006 | 0.228 | NMDA 2C receptor antagonist | 0.069 0.034 DBMET03702 0.228 0.005 DBMET03703 | DBMET03703 | |
| 0.172 | 0.02 | 0.261 | GABA C receptor antagonist | 0.261 0.005 DBMET03702 0.168 0.022 DBMET03703 | DBMET03702 | |
| 0.237 | 0.088 | 0.237 | Interleukin agonist | 0.228 0.096 DBMET03703 | ||
| 0.219 | 0.071 | 0.219 | Anticonvulsant | 0.156 0.122 DBMET03702 | ||
| 0.272 | 0.136 | 0.358 | GABA C receptor rho-3 antagonist | 0.358 0.082 DBMET03702 0.304 0.113 DBMET03703 | DBMET03702 | |
| 0.139 | 0.005 | 0.139 | 5 Hydroxytryptamine 2C agonist | 0.135 0.005 DBMET03702 0.092 0.009 DBMET03703 | ||
| 0.17 | 0.041 | 0.17 | Anesthetic local | 0.14 0.054 DBMET03703 | ||
| 0.218 | 0.091 | 0.218 | Neuropeptide Y2 antagonist | 0.199 0.12 DBMET03702 0.214 0.096 DBMET03703 | ||
| 0.194 | 0.083 | 0.2 | Psychostimulant | 0.2 0.08 DBMET03702 0.179 0.093 DBMET03703 | DBMET03702 | |
| 0.129 | 0.025 | 0.129 | ABCA1 expression enhancer | 0.129 0.025 DBMET03702 0.126 0.026 DBMET03703 | ||
| 0.307 | 0.204 | 0.309 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.309 0.201 DBMET03702 | DBMET03702 | |
| 0.221 | 0.118 | 0.248 | Gastrin inhibitor | 0.248 0.082 DBMET03702 | DBMET03702 | |
| 0.131 | 0.031 | 0.163 | Prolactin inhibitor | 0.118 0.04 DBMET03702 0.163 0.017 DBMET03703 | DBMET03703 | |
| 0.102 | 0.005 | 0.102 | Neurokinin 3 antagonist | 0.07 0.013 DBMET03702 0.071 0.012 DBMET03703 | ||
| 0.247 | 0.151 | 0.247 | Calcium channel activator | 0.227 0.175 DBMET03703 | ||
| 0.099 | 0.005 | 0.099 | Factor XIa inhibitor | 0.098 0.005 DBMET03702 0.062 0.012 DBMET03703 | ||
| 0.139 | 0.046 | 0.155 | Papain-like protease (SARS coronavirus) inhibitor | 0.146 0.038 DBMET03702 0.155 0.029 DBMET03703 | DBMET03703 | |
| 0.1 | 0.011 | 0.1 | Neurokinin antagonist | 0.06 0.025 DBMET03702 0.052 0.031 DBMET03703 | ||
| 0.098 | 0.014 | 0.123 | Opioid agonist | 0.123 0.01 DBMET03703 | DBMET03703 | |
| 0.109 | 0.032 | 0.153 | Porphobilinogen synthase inhibitor | 0.153 0.02 DBMET03703 | DBMET03703 | |
| 0.149 | 0.076 | 0.149 | Acetylcholine M1 receptor antagonist | 0.146 0.078 DBMET03702 0.146 0.078 DBMET03703 | ||
| 0.099 | 0.028 | 0.113 | Dopamine agonist | 0.08 0.037 DBMET03702 0.113 0.022 DBMET03703 | DBMET03703 | |
| 0.269 | 0.202 | 0.291 | 5 Hydroxytryptamine release inhibitor | 0.255 0.221 DBMET03702 0.291 0.175 DBMET03703 | DBMET03703 | |
| 0.078 | 0.015 | 0.095 | Dopamine D2 agonist | 0.056 0.023 DBMET03702 0.095 0.011 DBMET03703 | DBMET03703 | |
| 0.069 | 0.006 | 0.069 | 5-Alpha-reductase 1 inhibitor | 0.015 0.013 DBMET03702 0.054 0.007 DBMET03703 | ||
| 0.081 | 0.019 | 0.099 | Protein kinase C epsilon inhibitor | 0.099 0.013 DBMET03702 0.063 0.028 DBMET03703 | DBMET03702 | |
| 0.146 | 0.084 | 0.165 | Anticoagulant | 0.165 0.069 DBMET03702 0.125 0.106 DBMET03703 | DBMET03702 | |
| 0.085 | 0.024 | 0.085 | 5 Hydroxytryptamine 2A agonist | 0.082 0.026 DBMET03702 0.08 0.027 DBMET03703 | ||
| 0.096 | 0.037 | 0.108 | Somatostatin 1 agonist | 0.101 0.034 DBMET03702 0.108 0.029 DBMET03703 | DBMET03703 | |
| 0.139 | 0.082 | 0.141 | Hemostatic | 0.138 0.083 DBMET03702 0.141 0.08 DBMET03703 | DBMET03703 | |
| 0.093 | 0.036 | 0.17 | 5 Hydroxytryptamine agonist | 0.17 0.018 DBMET03702 | DBMET03702 | |
| 0.068 | 0.014 | 0.068 | 5-Alpha-reductase inhibitor | 0.035 0.028 DBMET03702 0.068 0.014 DBMET03703 | ||
| 0.06 | 0.009 | 0.078 | Opioid delta receptor agonist | 0.078 0.007 DBMET03703 | DBMET03703 | |
| 0.173 | 0.126 | 0.19 | 5 Hydroxytryptamine 3E antagonist | 0.19 0.081 DBMET03702 | DBMET03702 | |
| 0.164 | 0.118 | 0.204 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.204 0.069 DBMET03703 | DBMET03703 | |
| 0.053 | 0.009 | 0.057 | Factor XI inhibitor | 0.057 0.008 DBMET03702 0.036 0.021 DBMET03703 | DBMET03702 | |
| 0.101 | 0.061 | 0.122 | Anabolic | 0.092 0.074 DBMET03702 0.122 0.038 DBMET03703 | DBMET03703 | |
| 0.113 | 0.074 | 0.113 | Acetylcholine muscarinic antagonist | 0.111 0.078 DBMET03702 0.111 0.077 DBMET03703 | ||
| 0.269 | 0.23 | 0.328 | Caspase 9 stimulant | 0.328 0.165 DBMET03703 | DBMET03703 | |
| 0.13 | 0.091 | 0.329 | Peroxidase inhibitor | 0.329 0.032 DBMET03703 | DBMET03703 | |
| 0.061 | 0.024 | 0.061 | Dipeptidyl peptidase inhibitor | 0.053 0.035 DBMET03702 | ||
| 0.096 | 0.063 | 0.096 | Electrolyte absorption antagonist | 0.094 0.066 DBMET03702 | ||
| 0.162 | 0.129 | 0.333 | Aldehyde oxidase inhibitor | 0.333 0.059 DBMET03703 | DBMET03703 | |
| 0.098 | 0.065 | 0.16 | GABA C receptor rho-1 antagonist | 0.16 0.017 DBMET03702 0.088 0.082 DBMET03703 | DBMET03702 | |
| 0.102 | 0.069 | 0.102 | Ferrochelatase inhibitor | 0.088 0.086 DBMET03702 | ||
| 0.051 | 0.02 | 0.051 | Dipeptidyl peptidase IV inhibitor | 0.044 0.032 DBMET03702 | ||
| 0.08 | 0.051 | 0.09 | Na+ K+ transporting ATPase inhibitor | 0.075 0.055 DBMET03702 0.09 0.041 DBMET03703 | DBMET03703 | |
| 0.087 | 0.059 | 0.087 | Histamine N-methyltransferase inhibitor | 0.077 0.071 DBMET03703 | ||
| 0.067 | 0.039 | 0.067 | Acetylcholine M2 receptor antagonist | 0.062 0.043 DBMET03702 0.058 0.046 DBMET03703 | ||
| 0.078 | 0.05 | 0.078 | CYP2A6 inhibitor | 0.075 0.053 DBMET03702 | ||
| 0.05 | 0.024 | 0.052 | Neuraminidase (Influenza A) inhibitor | 0.052 0.021 DBMET03703 | DBMET03703 | |
| 0.109 | 0.084 | 0.109 | Cholinergic antagonist | 0.101 0.094 DBMET03703 | ||
| 0.143 | 0.12 | 0.167 | Neurotensin receptor agonist | 0.14 0.129 DBMET03702 0.167 0.066 DBMET03703 | DBMET03703 | |
| 0.042 | 0.021 | 0.049 | 5 Hydroxytryptamine 2B agonist | 0.049 0.014 DBMET03702 | DBMET03702 | |
| 0.062 | 0.043 | 0.063 | Prolactin release inhibitor | 0.063 0.039 DBMET03703 | DBMET03703 | |
| 0.057 | 0.038 | 0.057 | Kallikrein 1 inhibitor | 0.056 0.04 DBMET03702 0.052 0.047 DBMET03703 | ||
| 0.038 | 0.02 | 0.05 | Plasma kallikrein inhibitor | 0.05 0.012 DBMET03702 | DBMET03702 | |
| 0.039 | 0.023 | 0.042 | Tryptase inhibitor | 0.042 0.02 DBMET03702 | DBMET03702 | |
| 0.037 | 0.025 | 0.038 | Kinesin-like protein 1 inhibitor | 0.038 0.024 DBMET03703 | DBMET03703 | |
| 0.037 | 0.025 | 0.038 | Kinesin antagonist | 0.038 0.024 DBMET03703 | DBMET03703 | |
| 0.133 | 0.122 | 0.133 | Tumour necrosis factor antagonist | |||
| 0.025 | 0.015 | 0.034 | Glutamate (mGluR1) agonist | 0.034 0.007 DBMET03702 | DBMET03702 | |
| 0.173 | 0.163 | 0.21 | DNA synthesis inhibitor | 0.21 0.108 DBMET03702 0.198 0.126 DBMET03703 | DBMET03702 | |
| 0.106 | 0.096 | 0.106 | Cathepsin H inhibitor | |||
| 0.099 | 0.09 | 0.112 | TRPA1 agonist | 0.112 0.068 DBMET03703 | DBMET03703 | |
| 0.066 | 0.058 | 0.068 | Aminopeptidase I inhibitor | 0.068 0.056 DBMET03702 | DBMET03702 | |
| 0.044 | 0.036 | 0.054 | Kallikrein inhibitor | 0.054 0.027 DBMET03702 | DBMET03702 | |
| 0.014 | 0.006 | 0.014 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.012 0.009 DBMET03703 | ||
| 0.08 | 0.073 | 0.08 | Hematopoietic | 0.08 0.073 DBMET03703 | ||
| 0.079 | 0.072 | 0.102 | Estrogen-related receptor beta agonist | 0.087 0.047 DBMET03702 0.102 0.023 DBMET03703 | DBMET03703 | |
| 0.021 | 0.014 | 0.022 | Neuraminidase (Influenza B) inhibitor | 0.022 0.013 DBMET03703 | DBMET03703 | |
| 0.016 | 0.01 | 0.017 | NMDA receptor phencyclidine site antagonist | 0.017 0.009 DBMET03702 0.017 0.009 DBMET03703 | DBMET03703 | |
| 0.037 | 0.032 | 0.041 | Membrane dipeptidase inhibitor | 0.041 0.025 DBMET03702 | DBMET03702 | |
| 0.089 | 0.086 | 0.109 | Glutamate (mGluR7) agonist | 0.109 0.043 DBMET03702 | DBMET03702 | |
| 0.053 | 0.05 | 0.062 | Acetylcholine M3 receptor antagonist | 0.062 0.038 DBMET03703 | DBMET03703 | |
| 0.122 | 0.121 | 0.188 | GABA C receptor rho-2 antagonist | 0.188 0.036 DBMET03702 | DBMET03702 | |
| 0.03 | 0.028 | 0.035 | Glutamate (mGluR3) agonist | 0.035 0.016 DBMET03702 0.035 0.016 DBMET03703 | DBMET03703 | |
| 0.159 | 0.158 | 0.167 | DNA damaging | 0.167 0.149 DBMET03703 | DBMET03703 | |
| 0.079 | 0.078 | 0.091 | Protein kinase C delta inhibitor | 0.091 0.061 DBMET03702 | DBMET03702 | |
| 0.025 | 0.025 | 0.028 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.028 0.017 DBMET03702 | DBMET03702 | |
| 0.044 | 0.044 | 0.057 | 5 Hydroxytryptamine 2 agonist | 0.057 0.03 DBMET03702 | DBMET03702 | |
| 0.073 | 0.075 | 0.1 | Ornithine decarboxylase inhibitor | 0.1 0.045 DBMET03702 0.084 0.063 DBMET03703 | DBMET03702 | |
| 0.092 | 0.095 | 0.134 | DNA polymerase I inhibitor | 0.118 0.07 DBMET03702 0.134 0.059 DBMET03703 | DBMET03703 | |
| 0.076 | 0.085 | 0.083 | HIV-1 integrase (Overall Integration) inhibitor | 0.083 0.073 DBMET03703 | DBMET03703 | |
| 0.032 | 0.043 | 0.047 | Oxytocin agonist | 0.047 0.026 DBMET03703 | DBMET03703 | |
| 0.095 | 0.106 | 0.134 | Aldehyde dehydrogenase inhibitor | 0.134 0.058 DBMET03703 | DBMET03703 | |
| 0.037 | 0.05 | 0.044 | Histamine H1 receptor agonist | 0.044 0.03 DBMET03702 | DBMET03702 | |
| 0.054 | 0.067 | 0.057 | Trypsin inhibitor | 0.057 0.056 DBMET03702 | DBMET03702 | |
| 0.023 | 0.037 | 0.032 | Purinergic P2Y15 antagonist | 0.032 0.013 DBMET03702 | DBMET03702 | |
| 0.046 | 0.061 | 0.053 | Epithelial sodium channel blocker | 0.053 0.042 DBMET03702 | DBMET03702 | |
| 0.117 | 0.132 | 0.143 | Adenylate cyclase stimulant | 0.143 0.074 DBMET03702 0.139 0.082 DBMET03703 | DBMET03702 | |
| 0.052 | 0.07 | 0.075 | Beta adrenoreceptor antagonist | 0.075 0.032 DBMET03703 | DBMET03703 | |
| 0.096 | 0.119 | 0.128 | Nav1.2 sodium channel blocker | 0.128 0.074 DBMET03702 | DBMET03702 | |
| 0.09 | 0.113 | 0.103 | Calcium channel N-type blocker | 0.103 0.091 DBMET03702 | DBMET03702 | |
| 0.073 | 0.097 | 0.079 | CC chemokine 5 receptor agonist | 0.079 0.068 DBMET03703 | DBMET03703 | |
| 0.015 | 0.041 | 0.022 | Dopamine D1 agonist | 0.022 0.018 DBMET03703 | DBMET03703 | |
| 0.106 | 0.136 | 0.125 | Sphingosine 1-phosphate receptor 2 antagonist | 0.125 0.085 DBMET03702 | DBMET03702 | |
| 0.027 | 0.059 | 0.046 | Dopamine D5 agonist | 0.046 0.021 DBMET03703 | DBMET03703 | |
| 0.012 | 0.046 | 0.018 | Estrogen-related receptor gamma agonist | 0.018 0.014 DBMET03703 | DBMET03703 | |
| 0.025 | 0.06 | 0.051 | Vascular adhesion protein 1 inhibitor | 0.051 0.014 DBMET03702 | DBMET03702 | |
| 0.024 | 0.061 | 0.038 | Melatonin receptor 1A agonist | 0.038 0.016 DBMET03702 | DBMET03702 | |
| 0.058 | 0.097 | 0.075 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.075 0.047 DBMET03702 | DBMET03702 | |
| 0.173 | 0.215 | 0.191 | Antithrombotic | 0.191 0.189 DBMET03703 | DBMET03703 | |
| 0.04 | 0.083 | 0.057 | Sphingosine 1-phosphate receptor 3 antagonist | 0.057 0.043 DBMET03702 | DBMET03702 | |
| 0.043 | 0.087 | 0.063 | Sphingosine kinase inhibitor | 0.063 0.033 DBMET03702 | DBMET03702 | |
| 0.064 | 0.111 | 0.084 | MAP kinase kinase 7 inhibitor | 0.084 0.035 DBMET03703 | DBMET03703 | |
| 0.07 | 0.122 | 0.096 | Alpha 2b adrenoreceptor antagonist | 0.096 0.078 DBMET03702 | DBMET03702 | |
| 0.098 | 0.155 | 0.113 | Vanilloid 1 agonist | 0.113 0.107 DBMET03703 | DBMET03703 | |
| 0.059 | 0.117 | 0.072 | GABA B receptor agonist | 0.072 0.062 DBMET03703 | DBMET03703 | |
| 0.041 | 0.099 | 0.066 | Phenylalanine 4-hydroxylase inhibitor | 0.066 0.05 DBMET03703 | DBMET03703 | |
| 0.049 | 0.109 | 0.069 | Phospholipase D inhibitor | 0.069 0.055 DBMET03702 | DBMET03702 | |
| 0.025 | 0.086 | 0.041 | Opioid mu receptor agonist | 0.041 0.039 DBMET03703 | DBMET03703 | |
| 0.073 | 0.137 | 0.143 | Nav1.3 sodium channel blocker | 0.143 0.053 DBMET03702 | DBMET03702 | |
| 0.121 | 0.187 | 0.158 | Immunostimulant | 0.158 0.148 DBMET03703 | DBMET03703 | |
| 0.029 | 0.097 | 0.051 | Alcohol oxidase inhibitor | 0.051 0.044 DBMET03703 | DBMET03703 | |
| 0.047 | 0.117 | 0.061 | Histone deacetylase SIRT3 inhibitor | 0.061 0.047 DBMET03702 | DBMET03702 | |
| 0.075 | 0.147 | 0.112 | DOPA decarboxylase inhibitor | 0.112 0.055 DBMET03703 | DBMET03703 | |
| 0.145 | 0.229 | 0.187 | Nitric-oxide synthase stimulant | 0.187 0.112 DBMET03702 | DBMET03702 | |
| 0.038 | 0.123 | 0.057 | Heat shock protein 90 beta antagonist | 0.057 0.045 DBMET03702 | DBMET03702 | |
| 0.078 | 0.174 | 0.131 | Histone deacetylase SIRT1 inhibitor | 0.131 0.079 DBMET03702 | DBMET03702 | |
| 0.02 | 0.116 | 0.03 | DNA topoisomerase IV inhibitor | 0.03 0.02 DBMET03702 | DBMET03702 | |
| 0.072 | 0.176 | 0.106 | Toll-Like receptor 2 antagonist | 0.106 0.095 DBMET03703 | DBMET03703 | |
| 0.06 | 0.171 | 0.103 | Proteasome inhibitor | 0.103 0.083 DBMET03702 | DBMET03702 | |
| 0.043 | 0.155 | 0.088 | Heme oxygenase stimulant | 0.088 0.011 DBMET03702 | DBMET03702 | |
| 0.047 | 0.173 | 0.08 | Histamine H2 receptor antagonist | 0.08 0.065 DBMET03702 | DBMET03702 | |
| 0.048 | 0.176 | 0.096 | Creatine kinase inhibitor | 0.096 0.064 DBMET03703 | DBMET03703 | |
| 0.13 | 0.26 | 0.175 | Peptidyltransferase inhibitor | 0.175 0.138 DBMET03703 | DBMET03703 | |
| 0.035 | 0.165 | 0.081 | Epoxide hydrolase inhibitor | 0.081 0.04 DBMET03702 | DBMET03702 | |
| 0.141 | 0.274 | 0.194 | Insulysin inhibitor | 0.194 0.166 DBMET03702 | DBMET03702 | |
| 0.1 | 0.235 | 0.167 | Tumour necrosis factor alpha release inhibitor | 0.167 0.137 DBMET03702 | DBMET03702 | |
| 0.152 | 0.292 | 0.21 | Interleukin 2 agonist | 0.21 0.173 DBMET03703 | DBMET03703 | |
| 0.092 | 0.238 | 0.152 | Antipruritic | 0.152 0.092 DBMET03702 | DBMET03702 | |
| 0.057 | 0.214 | 0.122 | Thrombolytic | 0.122 0.108 DBMET03702 | DBMET03702 | |
| 0.159 | 0.364 | 0.279 | Calcium channel L-type activator | 0.279 0.175 DBMET03703 | DBMET03703 | |
| 0.018 | 0.243 | 0.042 | VCAM antagonist | 0.042 0.02 DBMET03702 | DBMET03702 | |
| 0.018 | 0.243 | 0.042 | VCAM-1 antagonist | 0.042 0.02 DBMET03702 | DBMET03702 | |
| 0.106 | 0.371 | 0.233 | Sodium/bile acid cotransporter inhibitor | 0.233 0.147 DBMET03703 | DBMET03703 | |
| 0.014 | 0.351 | 0.076 | DNA gyrase inhibitor | 0.076 0.03 DBMET03702 | DBMET03702 | |
| 0.036 | 0.398 | 0.123 | Estrogen antagonist | 0.123 0.049 DBMET03703 | DBMET03703 | |
| 0.017 | 0.502 | 0.106 | Estrogen receptor beta antagonist | 0.106 0.053 DBMET03703 | DBMET03703 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |